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Abstract
Background: Two major risk factors for the onset of fatty liver disease are excessive alcohol intake and obesity, the
latter being associated with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to examine the
effects of black rice extract (BRE) on hepatic steatosis and insulin resistance in high-fat diet-fed mice, providing a
model of NAFLD.
Methods: Twenty-four mice were randomly divided into three groups (n = 8 in each group): normal fat diet (ND),
high fat diet (HF), and high fat diet supplemented with 1% (w/w) BRE (HF +1% BRE). The experimental diets were
fed for seven weeks.
Results: A HF induced hepatic steatosis with significant increases in the serum levels of free fatty acids (FFAs),
triglyceride (TG), total cholesterol (TC), and insulin. By contrast, supplementary BRE (10 g/kg of diet) included in the
HF alleviated hepatic steatosis and significantly decreased serum TG and TC levels (p < 0.01 for both). Dietary BRE
also increased expression of fatty acid metabolism-related genes, including carnitine palmitoyltransferase (CPT1A),
acyl-CoA oxidase (ACO), cytochrome P450 (CYP4A10), and peroxisome proliferator activated receptor (PPAR)-a (p <
0.05 for all).
Conclusions: Dietary BRE supplementation improved serum lipid profiles and significantly enhanced mRNA
expression levels of fatty acid metabolism-related genes, primarily via b-oxidation and ω-oxidation in the liver.
Taken together, these findings suggest that a BRE-supplemented diet could be useful in reducing the risks of
hepatic steatosis and related disorders, including hyperlipidemia and hyperglycemia.
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Background
The liver is the primary fat-metabolizing organ. Normal
cellular fatty acid homeostasis is the product of a bal-
ance between fatty acid uptake, utilization, and export
from the liver, which is controlled by a complex tran-
scriptional network that is attuned to meeting the
energy requirements of cells while preventing excessive
accumulation of fatty acids [1]. However, excessive diet-
ary fat can result in increased free fatty acids (FFAs)
levels in the blood, thereby amplifying the delivery of
FFAs to the liver [2]. Thus, excessive consumption of
dietary fats induces lipid accumulation in the liver and
can eventually cause obesity. However, in studies of rats
subjected to short-term high-fat feeding, excess fat has
been shown to accumulate in the liver before adipose
tissue [3,4].
In the absence of alcohol consumption, viral infection,
or other specific etiologies, hepatic neutral lipid accumu-
lation has been defined as nonalcoholic fatty liver disease
(NAFLD) [5], which is the hepatic manifestation of meta-
bolic syndromes such as obesity, diabetes, and hyperlipi-
demia [1]. Although multiple metabolic abnormalities
may contribute to the development of fatty liver disease,
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[3,4,6]. Accordingly, NAFLD has become a major chal-
lenge to healthcare systems worldwide because of the
increasing prevalence of its major risk factors, namely
obesity and type 2 diabetes, which are closely linked to
overeating, physical inactivity, and metabolic syndrome
[7,8]. Therefore, an important consideration of current
research should be whether salutary metabolic effects,
such as prevention of hepatic lipid accumulation and
improvement of lipid profile, could be produced by phy-
tochemicals in food.
Numerous studies have suggested that natural com-
pounds in food can be important modulators in the pre-
vention of a variety of chronic diseases [9,10]. Increasing
evidence suggests that anthocyanins are potent antioxi-
dants, which are associated with protective effects
observed against inflammation, atherosclerosis, carcinoma,
and diabetes [11-17]. Anthocyanins are a class of water-
soluble natural pigments that belong to the large family of
flavonoids, responsible for the red, purple, and blue colors
of many plant materials [18,19]. Cyanidin-3-glucoside
(C3G) is the primary anthocyanin constituent in black rice
[20], an important source of anthocyanins in Asia [21].
Recent studies have reported that treatment with purified
C3G ameliorates adipose inflammation and hepatic steato-
sis in high-fat diet-fed mice [22], as well as hyperglycemia
in diabetic mice [23,24]. In addition, black rice contains
various bioactive phytochemicals, such as tocopherols,
tocotrienols, oryzanols, vitamin B complex, and phenolic
compounds [21,25].
We hypothesized that black rice containing C3G may
reduce the risk of hepatic fat accumulation and improve
insulin resistance in high-fat diet-fed mice and tested this
hypothesis in this study. Furthermore, we assumed that
crude black rice extract (BRE) may produce more potent
effect than the purified compounds, as crude extracts can
exert the additive or synergistic effects by the presence of
multi phytochemicals [26]. Moreover, the mechanism by
which anthocyanin treatment alleviates hepatic steatosis in
vivo is not yet fully understood. In the liver, fatty acid oxi-
dation occurs via mitochondrial and peroxisomal b-oxida-
tion and microsomal CYP4A-catalyzed ϖ-oxidation
[2,27-29]. The key enzymes involved in fatty acid oxidation
systems, such as CPT1A, ACO, and CYP4A10, are princi-
pally regulated by peroxisome proliferator-activated recep-
tor (PPAR)-a [2]. Therefore, to examine the mechanism
underlying BRE inhibition of hepatic fat accumulation, we
also measured the relative mRNA expression of PPAR-a,
CPT1A, ACO, and CYP4A10 in the liver.
Methods
Ethical approval
This experimental design was approved by the Institu-
tional Animal Care and Use Committee (IACUC) of the
National Academy of Agricultural Science (reference
number: NAAS-1114).
Materials
The pigmented black rice (Heugjinjubyeo, Oryza sativa L.)
was harvested in the experimental rice field of the
National Institute of Crop Science, Rural Development
Administration (Suwon, Korea, 2010). The rice seeds were
dehulled, milled in a laboratory mill, and passed through a
60-mesh sieve. The powdered black rice was extracted by
overnight shaking in a 10× volume of 80% ethanol solution
at room temperature. The extract was filtered through No.
6 filter paper (Advantec; Dublin, CA, USA). The filtrates
were concentrated into dry solids by sequential use of a
rotary evaporator (EYELA; Tokyo, Japan) and lyophilizer
(Ilshin Lab. Co.; Seoul, Korea). The final dried extract was
stored at -20°C until use. The BRE yield was 2.24% on the
basis of the fresh weight.
Analysis of anthocyanin composition and content in black
rice
Total anthocyanin components of BRE were measured
using liquid chromatography-mass spectrometry (LC-MS;
Waters Co., Milford, MA, USA) by comparing their reten-
tion time and MS data with control standards (Extrasynth-
èse; Genay, France) and our previous data [30]. BRE
(20 μL) was injected onto a Synergi Polar-RP 80A
reversed-phase column (4.6 × 250 nm I.D.; 4 μm Phenom-
enex; Torrance, CA, USA). The analysis was conducted at
a flow rate of 1 mL/min at a detection wavelength of 250-
600 nm (a representative wavelength of 525 nm) and the
oven temperature was 30°C. The mobile phases used were
5% formic acid in water (phase A) and 5% formic acid in
water/acetonitrile (1:1, v/v) (phase B). The pretreated sam-
ple was analyzed using the following gradient conditions: a
gradient of 20% to 50% B over a 30-min period; 50% B for
5 min; a gradient of 50% to 20% B over a 5-min period;
followed by a final wash with 20% B for 10 min. Figure 1
shows the anthocyanin profile of BRE. The contents of
C3G and peonidin-3-glucoside (P3G) in BRE were 23.21
mg/g and 1.69 mg/g, respectively. The total anthocyanin
value was expressed as the sum of C3G and P3G equiva-
lents per gram of BRE (mg/g). The total anthocyanin con-
t e n tw a sa sh i g ha s2 . 5 %o ft h eB R E .T h ep r o p o r t i o no f
C3G to total anthocyanin content was 93%. C3G was iden-
tified as the major peak in BRE.
Animals and diet
Five-week-old male C57BL/6 J mice were purchased from
Charles River Laboratories Japan, Inc (Tsukuba, Japan).
Mice were housed in Plexiglas cages (2 to 3 mice per
cage) and maintained in an air-conditioned room at 23 ±
3°C under an automatic lighting schedule. The mice were
allowed free access to water and a laboratory diet for
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mice were randomly blocked into three groups (n = 8 per
group) with a similar mean body weights. The mice in
one group were fed a normal diet (ND, 16.7% of calories
derived from fat), while those in the second group were
given a high-fat diet (HF, 45% of calories derived from
fat), and the third group was fed a high-fat diet supple-
mented with 1% BRE (HF + BRE1%, HF with 1% BRE of
diet weight). Finally, the C3G content of the 1% BRE diet
was 0.023% (0.23 g/kg of diet). The compositions of the
experimental diets are displayed in Table 1. The treat-
ment period was 7 wk.
Preparation of the blood and tissue samples
At the end of experimental period (7 wk), mice were
sacrificed after a 15-h starvation period. Blood samples
obtained by cardiac puncture were centrifuged at 2,000
rpm for 20 min at 4°C, and the serum supernatant was
t r a n s f e r r e dt oan e wm i c r o t u b ea n ds t o r e da t- 2 0 ° C
prior to use. The mouse livers were removed, rinsed
with cold phosphate-buffered saline, and then weighed.
Tissues were cut into pieces in a consistent manner.
Pieces to be used for histological evaluation were stored
in 10% buffered neutral formalin, and the remaining
pieces were placed in -70°C deep freezer.
Biochemical measurement
Serum FFAs concentration was measured by enzymatic
colorimetric methods (BioAssays Systems, Hayward, CA,
USA). Triglyceride (TG), total cholesterol (TC), and
HDL-cholesterol (HDL-C) concentrations were mea-
sured using a kit (Asan Pharmaceutical; Seoul, Korea)
based on an enzymatic colorimetric method. All proce-
dures were performed in accordance with the manufac-
turer’s instructions. LDL-cholesterol (LDL-C) was
calculated according to the following formula:
LDL − cholesterol = Total cholesterol − HDL − cholesterol − Triglyceride/5
Fasting glucose concentration was determined using a
portable glucometer (LifeScan; Milpitas, CA, USA).
Serum insulin concentration was measured using an
enzyme-linked immunosorbent assay (ELISA) kit
according to the manufacturer’s instructions (Millipore;
Bedford, MA, USA). The homeostasis model assessment
(HOMA) is a method used to quantify insulin resistance
and beta cell function [31]. The fasting blood glucose
level and serum insulin concentration were used to cal-
culate homeostasis model assessment-estimated insulin
resistance (HOMA-IR). One international unit of insulin
(1 IU) is defined as the biological equivalent of approxi-
mately 45.5 μg of pure crystalline insulin (precisely 1/22
mg). The following formula was used to calculate
HOMA-IR:
HOMA - IR = Fasting glucose

mg/dL

× Fasting insulin

mU/L

/405



&*
3*
$
%
&
Figure 1 Liquid chromatograms of anthocyanin extracted from
BRE (A), C3G standard (B), and P3G standard (C). Peak 1,
Cyanidin 3,5-diglucoside; Peak 2, Cyanidin-3-glucoside; Peak 3,
peonidin-3-glucoside; Peak 4, unknown (cyanidin-based).
Table 1 Composition of the experimental diets
1) (in
grams)
Ingredients ND HF HF + BRE 1%
Cornstarch 397.49 266.5 256.5
Dextrin 132 88.5 88.5
Sucrose 100 67.1 67.1
Fiber 50 50 50
Casein 200 240.4 240.4
Corn oil 70 11.34 11.34
Beef tallow - 215.46 215.46
Mineral Mix
2) 35 42.1 42.1
Vitamin Mix
2) 10 12 12
L-cysteine 3 3.6 3.6
Choline bitartrate 2.5 3 3
Tert-butylhydroquinone 0.014 0.017 0.017
Black rice extract
Cyanidin-3-glucoside
3)
--1 0
(0.23)
Total amount (g) 1000.0 1000.0 1000.0
1) Diets were prepared according to the AIN-93 G diet with slight
modifications
2) Mineral mixture and vitamin mixture were prepared according to AIN-93 G
diet
3) The content of C3G in black rice extract is based on LC/MS measurement
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Standardized pieces of liver tissue was fixed in 10% forma-
lin and embedded in paraffin. Sections were cut and
stained with hematoxylin and eosin (H&E). Images were
captured using an Olympus AX 70 camera (Japan). Hepa-
tic steatosis was graded as 0 (fatty hepatocytes occupying
< 5%), 1 (fatty hepatocytes occupying 5-33%), 2 (fatty
hepatocytes occupying 34-66%), or 3 (fatty hepatocytes
occupying > 66%) according to the percentage of hepatic
lipid [32]. Initial assessment was performed under low
magnification (40× to 200×) and confirmed under high
magnification (400×).
Determination of hepatic mRNA expression
T o t a lR N Aw a si s o l a t e df r o mt h ee x c i s e dm o u s el i v e r s
using Trizol reagent (Invitrogen; Carlsbad, CA, USA)
according to the manufacturer’sr e c o m m e n d a t i o n s .S i n g l e -
stranded cDNA was synthesized from 2 μg of total RNA
using the High Capacity RNA-to-cDNA Kit (Applied Bio-
systems; Foster City, CA, USA) according to the manufac-
turer’s instructions. Real-time quantitative PCR was
performed with a Step-One-Plus RT-PCR System (Applied
Biosystems). Relative mRNA levels were measured using
the system above via TaqMan analysis that employed
gene-specific primers and probes. The oligonucleotide
sequences of primers and probes for TaqMan analysis of
PPAR-a (Assay ID Mm00440939_ml); CPT1A (Assay ID
Mm00550438_ml); ACO (Assay ID Mm01246831_ml);
cytochrome P450, family 4, subfamily a, polypeptide 10
(CYP4A10) (Assay ID Mm Mm01188913_g1); and beta-
actin (Assay ID Mm00607939_sl) were all obtained from
Applied Biosystems. The relative expression levels of each
gene were determined by the 2
-ΔΔCt method. Cycling con-
ditions were as follows: one denaturing cycle at 95°C for
10 min, followed by 40 cycles at 95°C for 15 sec, and 60°C
for 1 min.
Statistical analysis
Data were expressed as mean ± SE for each group. All sta-
tistical analyses were performed with SAS 9.2 (SAS Insti-
tute; Cary, NY, USA). Results were analyzed by one-way
analysis of variance (ANOVA). When a significant differ-
ence was indicated, a Duncan’s multiple-range test was
performed to determine significant differences among the
groups. A p value < 0.05 was considered statistically
significant.
Results
Effect of BRE on body and liver weight
The initial and final body weights and relative liver
weights are shown in Table 2. The initial and final body
weights did not significantly differ among the three
groups, indicating that consumption of a high-fat diet for
7 wk did not affect mouse body weight. The relative liver
weight (per 100 g body weight) in the HF group was sig-
nificantly higher than in the ND group (p < 0.01). How-
ever, the HF + BRE 1% group had a lower mean liver
weight than the HF group (p < 0.01), suggesting that sup-
plementation of a high-fat diet with the 1% BRE diet
reduced liver weight. The food intake of high-fat diet
groups tended to decrease compared with that of ND,
but the calorie intake were similar for all groups (Addi-
tional file 1: Table S1).
Effect of BRE on lipid profile and insulin resistance index
T h es e r u mb a s i cb i o m a r k e r sd a t aa r es h o w ni nF i g u r e2 .
The serum FFAs, TG, and TC levels of the HF group were
significantly higher than those of the ND group (Figure 2;
p < 0.01 for all). High-fat diet reduced HDL-C level and
increased LDL-C level. Supplementation with 1% BRE
effectively reduced serum TG, TC and LDL-C levels, but
did not affect FFAs and HDL-C levels (Figure 2A). The
serum glucose, insulin levels, and HOMA-IR of the HF +
BRE1% group showed a trend towards reduction that
approached, but did not attain, statistical significance com-
pared to the HF group (Figure 3).
Effect of BRE on hepatic steatosis
To investigate the inhibitory effect of dietary BRE supple-
mentation on hepatic fat accumulation, we analyzed the
histology of liver tissue using H&E staining. Marked
microvesicular steatosis accompanied by a partial mild
inflammation was observed in the HF group, as shown in
Figure 4B. On the other hand, the degree of hepatic fat
accumulation was substantially alleviated by dietary intake
of BRE, as indicated by the reduced surface area of steato-
sis observed in livers from mice in the HF + BRE1% group
(Figure 4A). The average steatosis grade scores for the
ND, HF, and HF + BRE1% groups were 0, 2.63, and 0.25,
respectively (Figure 4B). The steatosis grade scores were
significantly lower in the BRE groups than in the HF
g r o u p( p<0 . 0 1 ) .W ef o u n dt h a tB R Es u p p l e m e n t a t i o n
was associated with a lower incidence of visible steatotic
livers in the HF + BRE1% group compared to the HF
group lacking BRE supplementation. Although, mice fed a
high-fat diet for 7 wk did not become obese, they did
Table 2 Body and liver weights of C57BL/6 J mice fed
different diets for 7 weeks
1)
Weight ND HF HF + BRE 1%
Initial body (g) 20.88 ± 0.47
NS 20.99 ± 0.36 20.13 ± 0.40
Final body (g) 32.65 ± 0.63
NS 32.24 ± 0.36 34.20 ± 0.65
Relative liver (% BW)
2) 3.80 ± 0.17
b 4.48 ± 0.23
a 3.18 ± 0.10
c
1) Values are expressed as mean ± standard error (n = 8 for each group).
Within the same row, means with different letters (a, b, or c) are significantly
different at p < 0.05 by Duncan’s multiple range test. NS; not significant by
ANOVA at p < 0.05
2) Relative liver weight is represented per 100 g of body weight (BW)
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Figure 2 Effect of BRE supplementation on serum lipid concentration. Concentrations of serum FFAs (A), TG (B), TC (C), HDL- C (D), LDL-C
(E), and HDL/LDL-C ratio (F) for each group during 7-wk feeding experiments. Data are expressed as mean ± standard error (n = 8 per group).
Means with different letters (a, b, or c) on the bar are significantly different from each other at p < 0.05 by Duncan’s multiple range test.
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Page 5 of 11exhibit hepatic fat accumulation similar to NAFLD. These
observations are consistent with the expectation that
excessive dietary fat accumulates in the liver before accu-
mulating in adipose tissue under high-fat dietary
conditions.
Effect of BRE on gene expression involved in fatty acid b-
oxidation in liver
Our measurements of relative mRNA expression of
PPAR-a,C P T 1 A ,A C O ,a n dC Y P 4 A 1 0i nt h el i v e rb y
real-time quantitative PCR are summarized in Figure 5.
The mRNA expression level of CPT1A, which is consid-
ered the rate-limiting enzyme in fatty acid oxidation, was
decreased in the HF group (Figure 5B; p < 0.01). The
mRNA expression levels for ACO and CYP4A10,
involved in peroxisomal b-oxidation and microsomal ω-
oxidation of fatty acids were also reduced in the HF
group (Figure 5C and 5D; p < 0.05 and p < 0.01, respec-
tively). On the other hand, dietary BRE supplementation
significantly increased the mRNA expression levels of
PPAR-a,C P T 1 A ,A C O ,a n dC Y P 4 A 1 0( F i g u r e5 ;H F+
BRE1% vs HD, p < 0.05 for all).
Discussion
The primary outcome of this study was the finding that
dietary BRE supplementation improved serum lipid pro-
files and attenuates hepatic steatosis in a high-fat diet
mouse model of NAFLD. It is our expectation that these
positive effects of BRE supplementation can likely be
attributed to the C3G within our BRE; C3G is known to
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Figure 3 Effect of BRE supplementation on blood concentration of glucose and insulin. Concentrations of fasting blood glucose (A), and
serum insulin (B), and insulin resistance index (C) for each group during 7-wk feeding experiments. HOMA-IR = fasting glucose (mg/dl) × fasting
insulin (mU/L)/405. Data are expressed as mean ± standard error (n = 8 per group). Means with different letters (a, b, or c) on the bar are
significantly different from each other at p < 0.05 by Duncan’s multiple range test.
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Figure 4 Effect of BRE supplementation on liver histology. Photomicrographs of H&E stained longitudinal liver sections from representative
animals in the ND, HF, and HF + BRE1% groups (magnification 400×) (A). Lipid droplets (arrows), microvesicular steatosis (arrow head), and mild
inflammation (circle) were observed in the HF liver sections. The HF group had a higher mean hepatic steatosis grade (0-3 scale) than the ND
and HF + BRE1% groups (B). Data are expressed as means ± standard error (n = 8 per group). Means with different letters (a, b, or c) on their
associated bars are significantly different from each other at p < 0.05 by Duncan’s multiple range test.
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Page 7 of 11exert anti-oxidative and anti-inflammatory effects [15,16].
This finding is highly promising, suggesting that salutary
effects such as those observed here may have the poten-
tial to reduce the risk of hepatic diseases, including
NAFLD. High-fat diet induced the decrease of the activ-
ities of the antioxidant enzyme such as SOD and CAT in
the liver [33]. It is believed that increased oxidative stress
have an effect on the development of NAFLD [34].
In this study, we found that HF mice had increased
serum levels of FFAs, TG, TC, and insulin, and an
increased HOMA-IR index compared to ND mice. These
findings fit with prior evidence indicating that higher
insulin levels co-exist with elevated levels of TC and TG
in the progressive state of NAFLD [35], as well as studies
showing that suppression of very-low-density lipoprotein
secretion and fatty acid b-oxidation produces hepatic TG
accumulation [5,6]. Although body weight change did
not differ among the groups in our study, we did observe
a significant increase in relative liver weight and hepatic
steatosis accompanied by a partial mild inflammationin
the HF group. Related research has shown that a short-
term high-fat causes hepatic steatosis in rats without any
significant increase in visceral or skeletal muscle fat
content [3,4].
We found that, in mice being fed a high-fat diet, dietary
BRE supplementation significantly reduced serum levels of
TG and TC and showed non-significant trends towards
reducing serum levels of glucose and insulin and HOMA-
IR. Although no significant effects of dietary BRE supple-
mentation on insulin resistance were observed in our
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Figure 5 Effect of BRE supplementation on mRNA levels of PPAR-a (A), CPT1A (B), ACO (C), and CYP4A10 (D) in liver of mice that
were fed different diets. Data are expressed as mean ± standard error (n = 8 per group). Means with different letters (a, b, or c) on the bar are
significantly different from each other at p < 0.05 by Duncan’s multiple range test.
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the HF + BRE1% group were associated with a reduction
in hepatic steatosis relative to that seen in the HF group
[35]. BRE supplementation was also associated with fewer
visible steatotic livers compared with that in mice fed a
high-fat diet without BRE supplementation. These results
suggest that BRE-supplemented mice had lower risk of
hyperlipidemia and were protected from reaching the pro-
gressive state of NAFLD.
Activation of AMP-activated protein kinase (AMPK)
downregulates enzymes involved in gluconeogenesis,
and subsequent activation of PPAR-a by AMPK
decreases TG levels in the liver by stimulating fatty acid
oxidation [36]. Tsuda et al. also suggested that AMPK
activation by cyanidin may be linked to the expression
of genes, including genes encoding adipokine and lipoly-
sis enzymes [17]. Guo et al. reported that supplementa-
tion with C3G (0.2%) attenuated obesity-associated
insulin resistance and hepatic steatosis in high-fat diet-
fed mice [22].
Previous studies have shown that PPAR-a,t o g e t h e r
with the products of its target genes (i.e., CPT1A, ACO,
and CYP4A10), is a critical player in the development of
NAFLD [2,29]. Thus, in an effort to examine the underly-
ing mechanisms of BRE inhibition of hepatic fat accumu-
lation, we measured the relative mRNA expression levels
of fatty acid metabolism-related genes, including PPAR-
a, CPT1A, ACO, and CYP4A10 and found that the
expression of these genes were reduced by a high-fat diet.
These findings complement recent studies reporting that
mRNA expression levels of CPT1A and ACO were
r e d u c e di na n i m a l sf e dh i g h - f a td i e t sf o r7~1 2w k
[1,27]. It is worth noting that the mice fed BRE-supple-
mented high-fat diet in our study had significantly higher
expression levels of PPAR-a,C P T 1 A ,A C O ,a n d
CYP4A10 than did the HF control mice. CPT1A is con-
sidered the rate-limiting enzyme in mitochondrial fatty
acid oxidation [27]. Microsomal ω-oxidation, which is
mediated by cytochrome p450 enzymes, plays a pivotal
role in energy homeostasis and lipid accumulation
[37,38]. Long-chain fatty acids and very long-chain fatty
acids are metabolized by the CYP4A ω-oxidation system
into dicarboxylic acids that then serve as substrates in
peroxisomal b-oxidation [39]. The upregulated PPAR-a-
dependent peroxisomal beta-oxidation pathway induced
in hepatic steatosis provides an alternative mechanism
for removal excessive fatty acids from the tissue [40].
Thus, we propose that supplementary BRE may prevent
hepatic steatosis induced by a high-fat diet by allowing
increased fatty acid oxidation. The additional mechanism
of inhibition of hepatic fat accumulation can be explained
by a down-regulation lipogenic genes including SREBP-
1c. König et al. reported that activation of PPAR-a
reduces triacylglycerol synthesis in rat hepatoma cells by
reduction of nuclear SREBP-1 [41]. Tsuda et al. showed
that dietary C3G-rich purple corn suppressed the mRNA
levels of enzymes involved in TG synthesis and lowed
SREBP-1 mRNA level in the liver [42]. However, in this
study, there was no significant difference in SREBP-1
gene expression of the liver among groups (Additional
file 2: Figure S1).
The role of fatty acid oxidation in the liver is contro-
versial. On one hand, fatty acid oxidation is viewed as a
protective mechanism for the disposal of potentially
toxic FFAs, but on the other hand, increased oxidation
of fatty acids can generate reactive oxygen species
(ROS), which cause tissue damage [40]. Peroxisomes
also have anti-oxidant enzymes to prevent ROS-
mediated cell damage [43]. Numerous in vitro and in
vivo studies have reported that black rice possesses anti-
oxidative effects [44-48]. Here, however, we did not
examine liver ROS levels or antioxidant enzymes such
as hepatic superoxide dismutase and catalase. It is note-
worthy that oxidative stress-related inflammation was
not apparent in the histology of our HF + BRE1%
group, suggesting that the BRE supplementation was not
associated with concerning levels of ROS-mediated cell
damage. Nevertheless additional research will be needed
t od e t e r m i n ew h e t h e rt h ep o s i t i v ee f f e c t so fB R Eo n
lipid metabolism and related antioxidant actions.
Conclusions
Dietary BRE supplementation significantly enhanced
mRNA expression levels of fatty acid metabolism-related
genes in the liver, most notably genes related to b-oxi-
dation and ω-oxidation. The enhancement of fatty acid
oxidation was not associated with an accumulation of
TG in the liver. These results suggest that black rice
containing C3G is a healthful food that may be useful in
the reducing the risks of hepatic steatosis and its related
disorders such as hyperlipidemia and hyperglycemia.
Additional material
Additional file 1: Table S1: Daily intakes of food and Calorie of
C57BL/6J mice fed in different diets for 7 weeks
1).
1)Value are
expressed as mean ± standard error (n = 3 per group). NS; not
significant by ANOVA at p < 0.05.
2)Daily food intake was determined
base on the total weekly intake per cage (2-3 mice/cage).
Additional file 2: Figure S1: Effect of BRE supplementation on
mRNA levels of SREBP-1 in liver of mice that were fed different
diets. Data are expressed as mean ± standard error (n = 8 per group).
Not significant by ANOVA at p < 0.05.
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